Literature DB >> 11673466

Rho-dependent agonist-induced spatio-temporal change in myosin phosphorylation in smooth muscle cells.

Koji Miyazaki1, Takeo Yano, David J Schmidt, Toshiya Tokui, Masao Shibata, Lawrence M Lifshitz, Satoshi Kimura, Richard A Tuft, Mitsuo Ikebe.   

Abstract

Agonist-induced translocation of RhoA and the spatio-temporal change in myosin regulatory light chain (MLC20) phosphorylation in smooth muscle was clarified at the single cell level. We expressed green fluorescent protein-tagged RhoA in the differentiated tracheal smooth muscle cells and visualized the translocation of RhoA in a living cell with three-dimensional digital imaging analysis. The stimulation of the cells by carbachol initiated the translocation of green fluorescent protein-tagged wild type RhoA to the plasma membrane within a minute. The change in MLC20 phosphorylation level after carbachol stimulation was monitored by using phospho-Ser-19-specific antibody recognizing the phosphorylated MLC20 in single cells. Cells expressing the dominant negative form (T19N) of RhoA significantly suppressed sustained MLC20 phosphorylation during the prolonged phase (>300 s), whereas the maximum phosphorylation level (reached at 10 s after stimulation) of these cells was not significantly different from the control cells. The kinetics of RhoA translocation was consistent with that of sustained myosin phosphorylation, suggesting the involvement of a RhoA pathway. Carbachol stimulation increased myosin phosphorylation within a minute both at the cortical and the central region. On the other hand, during prolonged phase, myosin phosphorylation was sustained at the cortical region of the cells but not at the central fibers. A myosin light chain kinase-specific inhibitor, ML-9, diminished myosin phosphorylation at the central region of the cells after the stimulation but not at the cortical area. On the other hand, Y-27632, a Rho kinase-specific inhibitor, diminished myosin phosphorylation at the cortical region but not the central region. The results clearly show that the myosin light chain kinase pathway and the Rho pathway distinctly change myosin phosphorylation in smooth muscle cells in both a temporal and spatial manner.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673466     DOI: 10.1074/jbc.M108568200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Modulation of fibroblast morphology and adhesion during collagen matrix remodeling.

Authors:  Elisa Tamariz; Frederick Grinnell
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

2.  Dynamics of neutrophil extravasation and vascular permeability are uncoupled during aseptic cutaneous wounding.

Authors:  Min-Ho Kim; Fitz-Roy E Curry; Scott I Simon
Journal:  Am J Physiol Cell Physiol       Date:  2009-01-28       Impact factor: 4.249

3.  Evidence that actomyosin cross bridges contribute to "passive" tension in detrusor smooth muscle.

Authors:  Paul H Ratz; John E Speich
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-07

4.  Androgens induce nongenomic stimulation of colonic contractile activity through induction of calcium sensitization and phosphorylation of LC20 and CPI-17.

Authors:  María C González-Montelongo; Raquel Marín; Tomás Gómez; Jorge Marrero-Alonso; Mario Díaz
Journal:  Mol Endocrinol       Date:  2010-03-05

5.  Agonist-induced changes in the phosphorylation of the myosin- binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle.

Authors:  Naohisa Niiro; Yasuhiko Koga; Mitsuo Ikebe
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

6.  Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway.

Authors:  Karnam S Murthy; Huiping Zhou; John R Grider; David L Brautigan; Masumi Eto; Gabriel M Makhlouf
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

Review 7.  The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction.

Authors:  Karl Swärd; Mitsuo Mita; David P Wilson; Jing Ti Deng; Marija Susnjar; Michael P Walsh
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

8.  Rho-kinase inhibition and electromechanical coupling in rat and guinea-pig ureter smooth muscle: Ca2+-dependent and -independent mechanisms.

Authors:  S Shabir; L Borisova; Susan Wray; T Burdyga
Journal:  J Physiol       Date:  2004-08-26       Impact factor: 5.182

9.  Little ROCK is a ROCK1 pseudogene expressed in human smooth muscle cells.

Authors:  Maria Claudia Montefusco; Kristen Merlo; Crystal D Bryan; Howard K Surks; Steven E Reis; Michael E Mendelsohn; Gordon S Huggins
Journal:  BMC Genet       Date:  2010-04-14       Impact factor: 2.797

10.  Rho-dependent kinase is involved in agonist-activated calcium entry in rat arteries.

Authors:  Philippe Ghisdal; Greet Vandenberg; Nicole Morel
Journal:  J Physiol       Date:  2003-07-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.